Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.022 USD | -26.67% | -51.22% | -95.87% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 221.4 | 255.1 | 111.3 | 216.9 | 41.78 | 6.36 |
Enterprise Value (EV) 2 | 201.8 | 248.7 | 99.44 | 159.8 | 47.39 | 29.66 |
P/E ratio | 12.8 x | -10.9 x | -1.72 x | -0.95 x | -0.5 x | -0.11 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 8.01 x | 10.4 x | 3.76 x | 4.63 x | 0.86 x | 0.12 x |
EV / Revenue | 7.3 x | 10.2 x | 3.36 x | 3.41 x | 0.97 x | 0.56 x |
EV / EBITDA | -10.6 x | -21 x | -1.72 x | -1.57 x | -0.74 x | -0.64 x |
EV / FCF | -52.7 x | -73 x | -4.44 x | -3.67 x | -1.29 x | -1.9 x |
FCF Yield | -1.9% | -1.37% | -22.5% | -27.3% | -77.3% | -52.7% |
Price to Book | 2.56 x | 3.7 x | 0.81 x | 1.49 x | 0.9 x | -0.54 x |
Nbr of stocks (in thousands) | 56.3 | 57.1 | 67.9 | 118 | 134 | 294 |
Reference price 3 | 3,934 | 4,466 | 1,638 | 1,834 | 311.4 | 21.60 |
Announcement Date | 6/5/18 | 6/12/19 | 6/10/20 | 7/15/21 | 7/7/22 | 7/17/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 27.65 | 24.44 | 29.58 | 46.81 | 48.8 | 52.62 |
EBITDA 1 | -18.99 | -11.84 | -57.68 | -101.8 | -63.9 | -46.65 |
EBIT 1 | -22.53 | -14.88 | -65.61 | -125.4 | -69.98 | -49.38 |
Operating Margin | -81.5% | -60.89% | -221.81% | -267.88% | -143.41% | -93.86% |
Earnings before Tax (EBT) 1 | 7.699 | -23.02 | -56.26 | -173.2 | -84.42 | -88.8 |
Net income 1 | 17.53 | -23.19 | -60.86 | -167.1 | -74.97 | -60.46 |
Net margin | 63.41% | -94.88% | -205.77% | -357.08% | -153.64% | -114.91% |
EPS 2 | 308.0 | -408.2 | -952.0 | -1,930 | -621.6 | -204.8 |
Free Cash Flow 1 | -3.826 | -3.405 | -22.4 | -43.58 | -36.64 | -15.64 |
FCF margin | -13.84% | -13.93% | -75.73% | -93.11% | -75.09% | -29.72% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 6/5/18 | 6/12/19 | 6/10/20 | 7/15/21 | 7/7/22 | 7/17/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 15.73 | 18.45 | 14.93 | 20.99 | 16.41 | 16.52 | 16.01 | 14.37 |
EBITDA 1 | -9.486 | -9.816 | -35.32 | -12.61 | -18.68 | -6.843 | -17.08 | -9.827 |
EBIT 1 | -21.71 | -21.12 | -37.27 | -18.57 | -54.36 | -9.555 | -54.94 | -9.807 |
Operating Margin | -137.96% | -114.52% | -249.69% | -88.45% | -331.21% | -57.84% | -343.21% | -68.24% |
Earnings before Tax (EBT) 1 | -13.96 | -20.94 | -48.6 | -8.39 | -51.04 | -0.6704 | -58.67 | -8.655 |
Net income 1 | -12.7 | -18.66 | -42.5 | -8.39 | -42.31 | -0.6731 | -35.01 | -8.655 |
Net margin | -80.75% | -101.15% | -284.7% | -39.97% | -257.76% | -4.07% | -218.7% | -60.22% |
EPS 2 | -112.0 | -154.0 | -340.0 | -56.24 | -215.8 | -2.427 | -117.4 | -16.26 |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 2/10/22 | 7/8/22 | 8/15/22 | 12/16/22 | 3/30/23 | 7/17/23 | 8/18/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 5.61 | 23.3 |
Net Cash position 1 | 19.6 | 6.4 | 11.8 | 57.1 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | -0.0878 x | -0.4994 x |
Free Cash Flow 1 | -3.83 | -3.41 | -22.4 | -43.6 | -36.6 | -15.6 |
ROE (net income / shareholders' equity) | 11.6% | -29.8% | -57.3% | -106% | -85.1% | -534% |
ROA (Net income/ Total Assets) | -13.4% | -9.85% | -31.7% | -38.8% | -30% | -45.4% |
Assets 1 | -130.6 | 235.4 | 192.2 | 430.3 | 250.2 | 133.1 |
Book Value Per Share 2 | 1,537 | 1,207 | 2,024 | 1,235 | 347.0 | -39.80 |
Cash Flow per Share 2 | 431.0 | 172.0 | 234.0 | 635.0 | 62.80 | 6.650 |
Capex 1 | 1.27 | 6.74 | 13.8 | 8.75 | 1.94 | 0.93 |
Capex / Sales | 4.58% | 27.57% | 46.61% | 18.69% | 3.97% | 1.77% |
Announcement Date | 6/5/18 | 6/12/19 | 6/10/20 | 7/15/21 | 7/7/22 | 7/17/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-95.87% | 108K | |
+112.55% | 1.99B | |
+131.75% | 76.27M | |
+203.85% | 47.48M |
- Stock Market
- Equities
- NEPTF Stock
- Financials Neptune Wellness Solutions Inc.